English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Methods are described for the gas chromatographic—mass spectrometric identification of the street drug  N -methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB or MDP-2-MB) and its differentiation from two uniquely isomeric drugs,  N -ethyl-3,4-methylenedioxyamphetamine (MDEA) and  N , N -dimethyl-3,4-methylenedioxyamphetamine (MDMMA). These positional isomers have the same molecular weight (MW = 207) and fragment by a common mechanism under electron impact mass spectrometric conditions to yield a base peak of the same mass ( m/z  72). Derivatization of the two secondary amines (MBDB and MDEA) with pentafluoropropionic anhydride (PFPA) yields amides with fragment ions which individualize their EI mass spectra. The PFPA derivative of MBDB yields diagnostic ions at  m/z  160 and 176, whereas the PFPA derivative of MDEA produces ions at  m/z  162 and 190. This EI spectra individualization for MBDB and MDEA is particularly significant since these two compounds have similar retention properties in the PFPA-derivatized and underivatized forms and since both are known street drugs.

journal of chromatographic science

Chromatographic and Mass Spectrometry Methods for the Differentiation of  N -Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine from Regioisomeric Derivatives